Subscribe To
Vyant bio says it is ‘well-positioned' to discover novel therapeutics to treat neurological diseases
Vyant Bio (NASDAQ:VYNT) Inc CEO Jay Roberts told shareholders that after its merger the company is “well-positioned” to pursue the discovery of no...
March 1, 2022, 12:20 pm
Ionis to present at the cowen annual health care conference
CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a pane...
March 1, 2022, 7:05 am
Ionis to present at the cowen annual health care conference
CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a pane...
March 1, 2022, 7:05 am
Ionis to present at the cowen annual health care conference
CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a pane...
March 1, 2022, 7:05 am
Harmony biosciences announces date of fourth quarter and full year 2021 financial results
PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated...
February 14, 2022, 8:05 am
Harmony biosciences announces date of fourth quarter and full year 2021 financial results
PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated...
February 14, 2022, 8:05 am
Harmony biosciences announces date of fourth quarter and full year 2021 financial results
PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated...
February 14, 2022, 8:05 am
Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain
RespireRx Pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have published a paper about its candidate KRM-II-81, ...
January 25, 2022, 8:43 am
Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain
RespireRx Pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have published a paper about its candidate KRM-II-81, ...
January 25, 2022, 8:43 am
Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain
RespireRx Pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have published a paper about its candidate KRM-II-81, ...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treat...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treat...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treat...
January 25, 2022, 8:43 am
Cortexyme and the gingipain hypothesis of alzheimer's disease
Cortexyme has a unique hypothesis- that Alzheimer's disease (AD) is caused by a neurological infection ...
October 11, 2021, 8:30 am
Cortexyme and the gingipain hypothesis of alzheimer's disease
Cortexyme has a unique hypothesis- that Alzheimer's disease (AD) is caused by a neurological infection ...
October 11, 2021, 8:30 am
Cortexyme and the gingipain hypothesis of alzheimer's disease
Cortexyme has a unique hypothesis- that Alzheimer's disease (AD) is caused by a neurological infection ...
October 11, 2021, 8:30 am
Pasithea therapeutics corp. and evotec se enter into drug development agreement
-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...
October 11, 2021, 8:20 am
Pasithea therapeutics corp. and evotec se enter into drug development agreement
-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...
October 11, 2021, 8:20 am
Pasithea therapeutics corp. and evotec se enter into drug development agreement
-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...
October 11, 2021, 8:20 am
Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference
ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...
October 8, 2021, 9:15 am